Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Mayne Pharma Group Limited | HG6 | 14. jui 2024 | 2.82 | +3.68 |
Merck KGAA | MRKC | 14. jui 2024 | 34.00 | -1.73 |
MGC Pharmaceuticals Ltd | H5O | 14. jui 2024 | 0.21 | 0.00 |
Mochida Pharmaceutical Co. Ltd. | MFY | 14. jui 2024 | 16.90 | +1.81 |
MPH Health Care AG | 93M1 | 14. jui 2024 | 32.60 | -3.55 |
N4 Pharma plc. | 0GO | 14. jui 2024 | 0.00 | 0.00 |
Otsuka Holdings Co.,Ltd. | OS1 | 14. jui 2024 | 37.00 | 0.00 |
Pharmanutra S.p.A. | 761 | 14. jui 2024 | 45.75 | -1.72 |
Provexis Plc | NZCA | 14. jui 2024 | 0.01 | 0.00 |
Roche Holding AG | RHO6 | 14. jui 2024 | 32.63 | +5.58 |
Santen Pharmaceutical Co. Ltd. | SZD | 14. jui 2024 | 9.30 | +1.64 |
SHANDONG XINHUA | XIN | 14. jui 2024 | 0.63 | +1.61 |
Shield Therapeutics plc | 1JS | 14. jui 2024 | 0.02 | +2.13 |
SHINEWAY PHARM | C1S | 14. jui 2024 | 0.93 | +2.20 |
Shionogi & Co. Ltd. | SH0 | 14. jui 2024 | 35.40 | -0.56 |
SIHUAN PHARM | TEL1 | 14. jui 2024 | 0.06 | +2.61 |
Solasia Pharma K.K. | 9SO | 14. jui 2024 | 0.15 | 0.00 |
Sumitomo Dainippon Pharma Co. Ltd | DPM | 14. jui 2024 | 1.98 | +1.54 |
Takeda Pharmaceutical Co | TKD | 14. jui 2024 | 24.35 | -0.45 |
TILT Holdings Inc | 0T01 | 14. jui 2024 | 0.03 | -9.68 |
Toho Holdings Co. Ltd. | TON | 14. jui 2024 | 22.20 | 0.00 |
TONG REN TANG | TNG | 14. jui 2024 | 0.63 | -1.56 |
Towa Pharmaceutical Co., Ltd. | 6QC | 14. jui 2024 | 17.60 | +1.15 |
UNITED LAB | UNJ | 14. jui 2024 | 0.84 | -11.11 |
Venture Life Group Plc | 17V | 14. jui 2024 | 0.47 | +1.72 |
Willow Biosciences Inc Ordinary Shares | 3D7 | 14. jui 2024 | 0.06 | -3.82 |
Zoetic International Plc | 7HR | 14. jui 2024 | 0.02 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.